aap Implantate AG

XETRA AAQ1.DE

aap Implantate AG Capital Expenditure for the year ending December 31, 2023: USD -448.12 K

aap Implantate AG Capital Expenditure is USD -448.12 K for the year ending December 31, 2023, a 13.64% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).

aap Implantate AG Capital Expenditure for the year ending December 31, 2022 was USD -518.92 K, a 12.84% change year over year.
aap Implantate AG Capital Expenditure for the year ending December 31, 2021 was USD -595.36 K, a -17.72% change year over year.
aap Implantate AG Capital Expenditure for the year ending December 31, 2020 was USD -505.73 K, a 73.32% change year over year.
aap Implantate AG Capital Expenditure for the year ending December 31, 2019 was USD -1.90 M, a 23.43% change year over year.

Key data

Date	Capital Expenditure	Free Cash Flow	Depreciation And Amortization	Deferred Income Tax

XETRA: AAQ1.DE

aap Implantate AG

CEO	Mr. Rubino Di Girolamo
IPO Date	May 11, 1999
Location	Germany
Headquarters	Lorenzweg 5
Employees	87
Sector	Healthcare
Industries Medical Instruments 3D Printing Automotive Parts Composite Materials Glass Hardware & Electronics Pharmaceuticals Plastics

Description

aap Implantate AG, a medical device company, develops, manufactures, and markets trauma products for orthopedics in Germany, the United States, and internationally. It offers LOQTEQ, an anatomical plating system for fracture treatment; and a range of cannulated screws, standard plates, and screws. The company sells its products directly to hospitals, buying syndicates, and hospital groups, as well as through a network of distributors under the aap brand name. aap Implantate AG was founded in 1990 and is headquartered in Berlin, Germany.

Key trends

Past 5 years